dexliq 4 mg/ml belsőleges oldat
laboratoires ctrs - dexametazon -
dexeto 4 mg tabletta
krka d.d., - dexametazon -
dexeto 8 mg tabletta
krka d.d., - dexametazon -
dexeto 20 mg tabletta
krka d.d., - dexametazon -
dexeto 40 mg tabletta
krka d.d., - dexametazon -
sarclisa
sanofi winthrop industrie - isatuximab - myeloma multiplex - daganatellenes szerek - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.